but myeloid cell production expands again over time. The researchers also found that changes in blood cell types across the lifetime can have important implications for blood cancers. They ...
Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...